SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is currently trending as investors weigh a combination of active debt reduction efforts, including bond-for-equity exchanges, against short-seller attacks and news of delayed 10-K filings. The community is deeply divided, with bulls pointing to the company's significant stakes in profitable assets like Babcock & Wilcox and Applied Digital as signs of a massive undervaluation, while bears remain focused on the firm's complex balance sheet and regulatory compliance hurdles.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is experiencing significant selling pressure amid broader sector volatility, with community sentiment deeply polarized between investors viewing the current price as a long-term accumulation opportunity and bears citing concerns over cash burn and certification timelines. The stock is a frequent subject of intense debate on social platforms as participants weigh its potential as a speculative EVTOL play against risks like pending legal challenges and geopolitical headwinds.

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals is surging following its acquisition by Biogen for approximately $5.6 billion, a deal that highlights strong sector interest in commercial-stage biotech assets. The community is actively discussing the successful exit for long-term shareholders who weathered volatility, while investors are now pivoting to identify other potential M&A candidates within the broader biotechnology landscape.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending following a strategic partnership with Nvidia and a two-billion-dollar investment aimed at scaling custom AI infrastructure, fueling excitement over potential data center dominance. Community sentiment is mixed as some investors celebrate the massive capital backing and future growth, while others express caution regarding broad market volatility and the impact of headline-driven price swings.

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending as the community leans into its long-standing presence on the Solana network and its distinct brand identity centered around humor. Participants are actively engaging with the ticker through persistent social media campaigns and cross-promoting the token alongside a wide variety of other assets to drive community visibility.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is currently trending as investors debate the impact of newly announced White House-backed air taxi integration pilot programs alongside ongoing legal friction with competitors regarding Chinese supply chain allegations. While bulls point to significant government contracts and FAA certification progress as proof of industry leadership, bears remain focused on high cash burn rates and intense volatility driven by aggressive institutional short-selling.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

SPY is trending as market participants digest conflicting reports regarding the potential de-escalation of military hostilities in the Middle East, with traders debating whether recent headlines signal a genuine shift in policy or another tactical maneuver. The community remains heavily divided, with intense discussions focused on the economic implications of persistent energy volatility and the credibility of administration communications amid broader market instability.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is currently seeing heavy community interest driven by anticipation of major contract wins and follow-on orders for its ultra-high-power wafer-level test and burn-in systems, particularly from key hyperscale data center and AI processor customers. Investors are closely tracking timelines for evaluation milestones and follow-on purchase orders, viewing the stock as a critical, undervalued play on the infrastructure expansion required for next-generation AI and silicon photonics hardware.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the announcement of $100 million in new financing, including a $75 million non-dilutive royalty agreement with Oberland Capital, which investors view as a key move to scale global operations and strengthen the company's balance sheet without significant dilution. While the stock continues to face intense pressure from short sellers and speculative volatility, the community is actively debating the impact of this capital injection on future growth, profitability timelines, and the potential for a short squeeze as the company expands its immunotherapy reach into new markets.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently in the spotlight as investors anticipate the upcoming SpaceX IPO, viewing the sector's increased visibility and potential for institutional inflows as a major growth catalyst. Community discussions heavily feature the company's recent acquisition approval of Mynaric and its growing defense contract backlog, leading to active debates about whether the current price action represents a buying opportunity or a consolidation phase ahead of further market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ImmunityBio, Inc. IBRX) announced on Tuesday that it has obtained $75 million in non-dilutive financing under its existing Royalty Interest Purchase Agreement (RIPA) with Oberland Capital, raising the total committed capital under the agreement to $375 million.&nbsp;In parallel with the RIPA funding, Nant Capital, LLC, affiliated with ImmunityBio’s Executive Chairman Patrick Soon-Shiong, M.D., converted $25 million of the outstanding promissory note into 4.6 million shares of common stock.This move has reduced the company's overall debt while reinforcing investor confidence.&nbsp;<a href="https://stocktwits.com/symbol/IBRX">ImmunityBio stock</a> traded over 4% higher on Tuesday’s premarket.&nbsp;Get updates to this developing story directly on Stocktwits.

In this photo illustration, the ImmunityBio logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

IBRX Stock Rises Pre-Market As $100M Financing Boosts Balance Sheet 

ImmunityBio, Inc. IBRX) announced on Tuesday that it has obtained $75 million in non-dilutive financing under its existing Royalty Interest Purchase Agreement (RIPA) with Oberland Capital.

Equity

The company has secured $75 million in non-dilutive financing from Oberland Capital.


Frame 485.png

Get the daily email that keeps you tuned in and makes markets fun again.

cryptotwits - 800x800.png

Get the daily crypto email you’ll actually love to read. It's value-packed, data-driven, and seasoned with wit.

Frame 479.png

The best trade ideas and analysis from the Stocktwits community. Delivered daily by 8 pm ET.

IBRX Stock Rises Pre-Market As $100M Financing Boosts Balance Sheet

Latest News